![SEBI directive to hike regulatory fees to impact BSE’s earnings by 20%](https://images.assettype.com/fortuneindia%2F2024-04%2F3ba1917d-0412-4384-a09c-63d58ddf839c%2FBSE_0104_copy.jpg?w=300&q=95)
SEBI directive to hike regulatory fees to impact BSE’s earnings by 20%
SEBI has asked BSE and MCX to pay the regulatory fee based on the notional value of their options contracts and not on the value of the premium value.
SEBI has asked BSE and MCX to pay the regulatory fee based on the notional value of their options contracts and not on the value of the premium value.
Snapping two sessions gaining streak, MCX shares declined 7.7% to hit an intraday low of ₹3,715.15 on the BSE.
The trading on MCX’s new web-based commodity derivatives platform began at 10.45 am on October 16
MCX plans to conduct mock trading on October 15, 2023, to allow members to participate, and validate setup and connection
In the early trade, the MCX stock surges to an intra-day high of 2,139, up 4.6% as compared to the previous close
MCX says it'll continue to conduct CDP mock tests pending further directions in the matter from SEBI
The contract has been extended for the third time for six months due to further delay in delivery of the trading software by TCS.
SEBI on Wednesday allowed foreign portfolio investors (FPIs) to participate in the exchange-traded commodity derivatives market
At event to kick off silver jubilee celebrations, NSE chief Vikram Limaye indicates settlement in sight with SGX.
Once described as the biggest innovator in the Indian financial market, what’s going to be his fate and that of his exchanges?